Korea Research Institute of Bioscience and Biotechnology

Myung-ho Sohn

Young Woo Park

Joon-Goo Jung

Jae Won Jeon

Jung Jae Yu

Ji Hyun Park

Myeoung Hee Jang

So-Young Choi

Sungsub Kim

Eun-Jung Song

Young-Soon Jang

Ho Jun Kim

Mi-La Cho

Ho Youn Kim

Hye In Choi

Ji-Hun Moon

The present invention relates to an anti-inflammatory composition using the antibody specifically binding to CD93 or its soluble fragment, and a diagnostic method and a diagnostic kit for inflammatory disease using CD93 or its soluble fragment specific antibody or aptamer.

CD93 or use of soluble fragment thereof

The present invention relates to a transmembrane protease, serine (TMPRSS4)-specific human antibody, and more particularly to a human antibody including a complementarity determining region (CDR) and a framework region (FR) derived from a human antibody specifically bound to TMPRSS4. The TMPRSS4-specific human antibody expressed in the various kinds of cancer cells of the present invention may be used in diagnosis of the cancer, classification of the disease, visualization, treatment, and prognostic evaluation.

TMPRSS4-specific human antibody

The present invention relates to a vascular endothelial growth factor (VEGF)-specific human antibody, and more particularly to a human antibody including a complementarity determining region (CDR) and a framework region (FR) derived from a human antibody specifically bound to VEGF. The VEGF-specific human antibody of the present invention may be used in diagnosis of diseases caused by the VEGF-overexpression, classification of the diseases, visualization, treatment, and prognostic evaluation.

VEGF-specific human antibody

Growing community of inventors

Daejeon, South Korea

Myung-ho Sohn